Project Description

CureSpec was Founded in 2020.

Our first market-ready product, Nephrospec™ is intended for the interrelated treatment of: 

– CKD (Chronic Kidney Disease)

– Hypertension (High Blood Pressure)

NephroSpec – Saving lives & costs

NephroSpec promotes new blood vessel formation and restores damaged tissue function by means of its patented ShockWave technology. We hold an Established, market-ready product, with a strong IP portfolio, which includes a granted U.S. patent, a fully developed CE-Marked device & Promising preliminary clinical results.

CureSpec has an established Production facility, a Global distribution chain and an experienced management team.

We are looking for partners for entry into the Ghanaian market. Kindly reach out to our health sector lead David Kumah. to learn more